Total Payments
$348,496
2024 Payments
$38,107
Companies
13
Transactions
325
Medicare Patients
1,198
Medicare Billing
$119,739
Payment Breakdown by Category
Other$282,727 (81.1%)
Consulting$33,807 (9.7%)
Travel$22,328 (6.4%)
Food & Beverage$9,606 (2.8%)
Education$28.42 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $282,727 | 113 | 81.1% |
| Consulting Fee | $33,807 | 26 | 9.7% |
| Travel and Lodging | $22,328 | 57 | 6.4% |
| Food and Beverage | $9,606 | 126 | 2.8% |
| Education | $28.42 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $118,317 | 135 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $44,336 | 31 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $43,053 | 23 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $38,433 | 33 | $0 (2019) |
| PFIZER INC. | $36,002 | 28 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $33,673 | 12 | $0 (2017) |
| Lilly USA, LLC | $20,893 | 24 | $0 (2024) |
| Allergan, Inc. | $8,400 | 20 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $3,000 | 2 | $0 (2017) |
| Celgene Corporation | $1,409 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,107 | 33 | ABBVIE INC. ($23,140) |
| 2023 | $38,260 | 52 | AbbVie Inc. ($23,601) |
| 2022 | $57,133 | 49 | ABBVIE INC. ($25,680) |
| 2021 | $30,050 | 25 | E.R. Squibb & Sons, L.L.C. ($13,483) |
| 2020 | $7,689 | 9 | Takeda Pharmaceuticals U.S.A., Inc. ($3,891) |
| 2019 | $40,806 | 37 | Takeda Pharmaceuticals U.S.A., Inc. ($15,819) |
| 2018 | $60,403 | 58 | PFIZER INC. ($21,201) |
| 2017 | $76,047 | 62 | Takeda Pharmaceuticals America, Inc. ($33,673) |
All Payment Transactions
325 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $937.50 | General |
| Category: Immunology | ||||||
| 07/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $106.06 | General |
| Category: IMMUNOLOGY | ||||||
| 06/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 05/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Immunology | ||||||
| 05/02/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Immunology | ||||||
| 04/22/2024 | Celgene Corporation | ZEPOSIA (Drug) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Neuroscience | ||||||
| 03/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $477.98 | General |
| Category: IMMUNOLOGY | ||||||
| 03/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $160.19 | General |
| Category: IMMUNOLOGY | ||||||
| 03/25/2024 | Lilly USA, LLC | OMVOH (Drug) | Travel and Lodging | Cash or cash equivalent | $167.50 | General |
| Category: Immunology | ||||||
| 03/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,562.50 | General |
| Category: Immunology | ||||||
| 03/15/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 03/15/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Immunology | ||||||
| 03/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | Cash or cash equivalent | $107.51 | General |
| Category: Immunology | ||||||
| 03/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $734.63 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $453.98 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $422.89 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $176.28 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 327 | 359 | $527,168 | $31,902 |
| 2022 | 10 | 335 | 356 | $568,367 | $33,617 |
| 2021 | 11 | 328 | 360 | $523,041 | $35,565 |
| 2020 | 10 | 208 | 219 | $304,650 | $18,655 |
Total Patients
1,198
Total Services
1,294
Medicare Billing
$119,739
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 65 | 67 | $251,074 | $8,104 | 3.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 86 | 97 | $34,425 | $6,242 | 18.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 44 | 49 | $27,097 | $5,065 | 18.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 19 | 19 | $88,654 | $3,535 | 4.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $16,416 | $2,633 | 16.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 30 | 30 | $84,270 | $2,035 | 2.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 25 | $8,375 | $1,488 | 17.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 12 | 12 | $8,904 | $1,412 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 33 | 33 | $7,953 | $1,388 | 17.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 82 | 82 | $298,480 | $10,325 | 3.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 58 | 70 | $37,590 | $7,287 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 71 | 79 | $27,742 | $5,394 | 19.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 13 | 14 | $63,420 | $2,418 | 3.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 18 | 18 | $10,134 | $1,771 | 17.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 31 | 31 | $84,537 | $1,714 | 2.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 12 | 12 | $8,640 | $1,581 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 26 | 26 | $6,084 | $1,220 | 20.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $26,220 | $1,011 | 3.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $5,520 | $896.24 | 16.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 70 | 92 | $48,908 | $9,936 | 20.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 64 | 66 | $233,244 | $7,968 | 3.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 59 | 66 | $22,583 | $4,959 | 22.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 19 | 19 | $13,281 | $2,635 | 19.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 11 | 11 | $48,378 | $2,066 | 4.3% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 12 | 12 | $36,360 | $1,614 | 4.4% |
About Dr. Daniel Stein, M.D
Dr. Daniel Stein, M.D is a Internal Medicine healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700968880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Stein, M.D has received a total of $348,496 in payments from pharmaceutical and medical device companies, with $38,107 received in 2024. These payments were reported across 325 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($282,727).
As a Medicare-enrolled provider, Stein has provided services to 1,198 Medicare beneficiaries, totaling 1,294 services with total Medicare billing of $119,739. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Gastroenterology
- Location Milwaukee, WI
- Active Since 10/19/2006
- Last Updated 12/29/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1700968880
Products in Payments
- Entyvio (Biological) $61,656
- SKYRIZI (Biological) $48,254
- ZEPOSIA (Drug) $43,122
- STELARA (Biological) $39,356
- RINVOQ (Biological) $26,260
- INFLECTRA (Biological) $18,546
- XELJANZ (Drug) $15,406
- ENTYVIO (Biological) $14,614
- Humira (Biological) $14,120
- OMVOH (Drug) $12,300
- HUMIRA (Biological) $6,654
- LINZESS (Drug) $4,400
- APRISO (Drug) $1,500
- XIFAXAN (Drug) $1,500
- VIBERZI (Drug) $300.00
- ELEVIEW (Device) $41.56
- Kanuma (Drug) $14.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Milwaukee
Dr. Jeremiah Depta, M.d, M.D
Internal Medicine — Payments: $686,844
Internal Medicine $686,844
Dr. Binod Dhakal, Md, MD
Internal Medicine — Payments: $605,281
Internal Medicine $605,281
Dr. Lee Biblo, Md, MD
Internal Medicine — Payments: $382,388
Internal Medicine $382,388
Nirav Shah, Md, MD
Internal Medicine — Payments: $280,591
Internal Medicine $280,591
Gilbert Jenouri, M.d, M.D
Internal Medicine — Payments: $229,172
Internal Medicine $229,172
Dr. Erik Stilp, Md, MD
Internal Medicine — Payments: $168,213
Internal Medicine $168,213